Skip to main content

Research Repository

Advanced Search

All Outputs (53)

Patients’ perspectives on medication adherence feedback interventions for managing long-term medications: a systematic review of qualitative evidence (2025)
Journal Article
Kobson, B., Hanley, J., Mair, A., Dima, A. L., Rea, N., & Paterson, R. E. (online). Patients’ perspectives on medication adherence feedback interventions for managing long-term medications: a systematic review of qualitative evidence. International Journal of Clinical Pharmacy, https://doi.org/10.1007/s11096-025-01958-4

Introduction
Optimising medication usage is a worldwide challenge. While numerous feedback interventions have been developed to address this issue, understanding patients' perspectives on the use of such interventions to optimise adherence provides... Read More about Patients’ perspectives on medication adherence feedback interventions for managing long-term medications: a systematic review of qualitative evidence.

Quality prescribing for Benzodiazepines and z-drugs: guide for improvement 2024 to 2027 (2024)
Report
Cook, A., Mair, A., Smith, G., & Strath, A. (2024). Quality prescribing for Benzodiazepines and z-drugs: guide for improvement 2024 to 2027

Benzodiazepines and z-drugs are indicated for a variety of conditions including the short-term relief of severe insomnia and some anxiety disorders. People can quickly become tolerant to the therapeutic effects of benzodiazepines and z-drugs, renderi... Read More about Quality prescribing for Benzodiazepines and z-drugs: guide for improvement 2024 to 2027.

Safe Prescribing and Monitoring in the Older Person (2024)
Book Chapter
Mair, A. R., Mair, A. R., Hilmer, S., & Kouladjian O’Donnell, L. (2024). Safe Prescribing and Monitoring in the Older Person. In J. Jose, A. R. Cox, & V. Paudyal (Eds.), Principles and Practice of Pharmacovigilance and Drug Safety (459-482). Springer. https://doi.org/10.1007/978-3-031-51089-2_20

This chapter will consider the main factors that increase the risk of adverse drug reactions and events in older people. This will include changes in physiology that affect the older person. It will also outline how older people should be prioritized... Read More about Safe Prescribing and Monitoring in the Older Person.

Polypharmacy and Deprescribing (2024)
Book Chapter
Mair, A. R., Jordon, M., & Mullan, J. (2024). Polypharmacy and Deprescribing. In J. Jose, A. R. Cox, & V. Paudyal (Eds.), Principles and Practice of Pharmacovigilance and Drug Safety (405-435). Springer. https://doi.org/10.1007/978-3-031-51089-2_18

Polypharmacy contributes to medication-related harm. Medication-related harm accounts for approximately 9% of hospital admissions worldwide, and it is estimated that many of these hospitalisations are preventable. It is therefore important to conside... Read More about Polypharmacy and Deprescribing.

Quality prescribing for antidepressants: guide for improvement 2024 to 2027 (2024)
Report
Cook, A., Mair, A., Smith, G., & Strath, A. (2024). Quality prescribing for antidepressants: guide for improvement 2024 to 2027

The prescribing of antidepressants continues to increase in Scotland, with many people receiving antidepressants for two years or more. This may be appropriate for some individuals, but it is important that ongoing treatment is reviewed regularly and... Read More about Quality prescribing for antidepressants: guide for improvement 2024 to 2027.

Type 2 Diabetes Mellitus - quality prescribing strategy: improvement guide 2024 to 2027 (2024)
Report
Mair, A., Kennon, B., Chalmers, J., Smith, G., Strath, A., McMahon, A., & Leitch, J. (2024). Type 2 Diabetes Mellitus - quality prescribing strategy: improvement guide 2024 to 2027. Scottish Government

This quality prescribing guide is intended to support clinicians across the multidisciplinary team and people with Type 2 Diabetes Mellitus (T2DM) in shared decision-making and the effective use of medicines, and offers practical advice and options f... Read More about Type 2 Diabetes Mellitus - quality prescribing strategy: improvement guide 2024 to 2027.

Proceedings of the International Ambulatory Drug Safety Symposium: Munich, Germany, June 2023 (2023)
Journal Article
Alexander, G. C., Budnitz, D., Hughes, C., Maas, R., Mair, A., McDonald, E. G., Meid, A. D., Payne, R., Seidling, H. M., Shakir, S., Suissa, S., Tannenbaum, C., Schneeweiss, S., & Dreischulte, T. (2024). Proceedings of the International Ambulatory Drug Safety Symposium: Munich, Germany, June 2023. Drug Safety, 47(1), 103-111. https://doi.org/10.1007/s40264-023-01362-9

Meeting report.

Optimizing polypharmacy management in the elderly: a comprehensive European benchmarking survey and the development of an innovative online benchmarking application (2023)
Journal Article
Kardas, P., Mair, A., Stewart, D., & Lewek, P. (2023). Optimizing polypharmacy management in the elderly: a comprehensive European benchmarking survey and the development of an innovative online benchmarking application. Frontiers in Pharmacology, 14, Article 1254912. https://doi.org/10.3389/fphar.2023.1254912

Background: Polypharmacy, defined as the simultaneous use of multiple medications by a patient, is a worldwide problem of rising prevalence. Paving the way for drug interactions, adverse drug reactions and non-adherence, it leads to negative health o... Read More about Optimizing polypharmacy management in the elderly: a comprehensive European benchmarking survey and the development of an innovative online benchmarking application.

Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper (2023)
Journal Article
van Poelgeest, E., Seppala, L., Bahat, G., Ilhan, B., Mair, A., van Marum, R., Onder, G., Ryg, J., Fernandes, M. A., Cherubini, A., Denkinger, M., Eidam, A., Egberts, A., Gudmundsson, A., Koçak, F. Ö. K., Soulis, G., Tournoy, J., Masud, T., Wehling, M., & van der Velde, N. (2023). Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper. European Geriatric Medicine, 14(6), 1195-1209. https://doi.org/10.1007/s41999-023-00872-0

Key summary points: Aim: To summarize the literature on medication review and deprescribing in older adults, and formulate recommendations to improve prescribing medications in older, multimorbid adults with polypharmacy. Findings: Current evidence d... Read More about Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper.

iSIMPATHY Evaluation Report (2023)
Book
Mair, A., Kirke, C., Scott, M., Michael, N., Kanan, Y., Law, S., Scullin, C., Fleming, G., Hyder Skinner, N., & Kyle, D. (2023). iSIMPATHY Evaluation Report

Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes (2023)
Journal Article
Urbańczyk, K., Guntschnig, S., Antoniadis, V., Falamic, S., Kovacevic, T., Kurczewska-Michalak, M., Miljković, B., Olearova, A., Sviestina, I., Szucs, A., Tachkov, K., Tiszai, Z., Volmer, D., Wiela-Hojeńska, A., Fialova, D., Vlcek, J., Stuhec, M., Hogg, A., Scott, M., Stewart, D., …Kardas, P. (2023). Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes. Frontiers in Pharmacology, 14, Article 1244151. https://doi.org/10.3389/fphar.2023.1244151

Clinical pharmacy as an area of practice, education and research started developing around the 1960s when pharmacists across the globe gradually identified the need to focus more on ensuring the appropriate use of medicines to improve patient outcome... Read More about Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes.

Evidence of the Impact of Interventions to Decrease Polypharmacy (2023)
Book Chapter
Mair, A. (2023). Evidence of the Impact of Interventions to Decrease Polypharmacy. In Encyclopaedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy. Springer. https://doi.org/10.1007/978-3-030-50247-8_146-1

As many as 50% of all patients with long-term conditions are using their medicines in a way that is not fully effective. This results in suboptimal treatment of their condition and attendance or admission to hospital. There is a significant level of... Read More about Evidence of the Impact of Interventions to Decrease Polypharmacy.

Cochrane EPOC Protocol: Providing medication adherence feedback to healthcare providers. The effect on care and outcomes. Protocol for a Cochrane review update (2022)
Other
Hassett, R., Sabatier, B., Savoldelli, V., Mair, A., Hanley, J., Dima, A., & Paterson, R. (2022). Cochrane EPOC Protocol: Providing medication adherence feedback to healthcare providers. The effect on care and outcomes. Protocol for a Cochrane review update

This is a protocol for a Cochrane Review (update).

Background
Key barriers to effectively supporting adherence include poor awareness amongst healthcare professionals (HCPs), scarce clinical tools and interventions, and suboptimal patient-provide... Read More about Cochrane EPOC Protocol: Providing medication adherence feedback to healthcare providers. The effect on care and outcomes. Protocol for a Cochrane review update.

Polypharmacy and Integrated Care (2021)
Book Chapter
Mair, A., & Alonso, A. (2021). Polypharmacy and Integrated Care. In V. Amelung, V. Stein, E. Suter, N. Goodwin, E. Nolte, & R. Balicer (Eds.), Handbook Integrated Care (453-477). Springer. https://doi.org/10.1007/978-3-030-69262-9_27

Safe and effective pharmacological treatment remains one of the greatest challenges in medicine, where models of healthcare delivery lag behind the enormous growth in single disease focused treatment with medicines. The implications for safe, efficie... Read More about Polypharmacy and Integrated Care.

Appropriate polypharmacy: a barometer for integrated care (2020)
Journal Article
Mair, A., Antoniadou, E., Hendry, A., & Gabrovec, B. (2021). Appropriate polypharmacy: a barometer for integrated care. Journal of Integrated Care, 29(2), 204-214. https://doi.org/10.1108/jica-04-2020-0019

Purpose
Polypharmacy, the concurrent use of multiple medicines by one individual, is a common and growing challenge driven by an ageing population and the growing number of people living longer with chronic conditions. Up to 11% of unplanned hospita... Read More about Appropriate polypharmacy: a barometer for integrated care.